Arthritis Drugs in the Medical Literature This Month - August 2006





Quantitative Assessment of the Gastrointestinal and Cardiovascular Risk-Benefit of Celecoxib Compared to Individual NSAIDs at the Population Level

Journal: Pharmacoepidemiology and Drug Safety 2006 Aug 9; [Epub ahead of print]

Authors: C. Varas-Lorenzo, A. Maguire, J. Castellsague, S. Perez-Gutthann

Summary: Our objective was to estimate the net cardiovascular (CV) (coronary heart disease, stroke, congestive heart failure) and gastrointestinal (GI) (peptic ulcer complications) risk-benefit public health impact of the use of celecoxib compared to non-selective NSAIDs in the arthritis population. We simulated the natural history of CV and GI disease in the U.S. …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

April 08, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's MDL Conference

March 26, 2025 - Charlotte, NC
Omni Charlotte Hotel

MORE DETAILS